In this insightful episode of the Veterinary Cancer Pioneers Podcast, Dr. Rachel Venable welcomes the esteemed Dr. Chand Khanna, founder and board chair of Ethos Discovery and a trailblazer in the field of veterinary and human oncology. With a remarkable career spanning academia, research, and clinical practice, Dr. Khanna shares his invaluable perspectives on the art of "communicative medicine" in veterinary oncology. Dr. Khanna provides an exciting update on the groundbreaking research being conducted at Ethos Discovery. He discusses the nationwide randomized prospective clinical trial for splenic hemangiosarcoma, which has already yielded valuable insights challenging conventional wisdom and offering new hope for curative outcomes. Join us to discover how these findings could revolutionize the treatment of canine cancer. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related